share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  07/16 17:32
Moomoo AI 已提取核心訊息
Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction, dated 07/15/2024, did not specify the number of shares involved or the transaction price. Details regarding the nature of the shares, the number of shares held after the action, and the total value of shares were not disclosed. This announcement is part of the company's regular financial disclosures.
Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction, dated 07/15/2024, did not specify the number of shares involved or the transaction price. Details regarding the nature of the shares, the number of shares held after the action, and the total value of shares were not disclosed. This announcement is part of the company's regular financial disclosures.
輝瑞公司(PFE)報告了一筆牽涉到其主席兼首席執行官艾伯特·布爾拉的交易。交易日期爲07/15/2024,未指定涉及的股份數量或交易價格。未披露有關股份性質、行動後持有的股份數量以及股份總價值的詳細信息。此公告是公司定期財務披露的一部分。
輝瑞公司(PFE)報告了一筆牽涉到其主席兼首席執行官艾伯特·布爾拉的交易。交易日期爲07/15/2024,未指定涉及的股份數量或交易價格。未披露有關股份性質、行動後持有的股份數量以及股份總價值的詳細信息。此公告是公司定期財務披露的一部分。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息